| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +4 M | 100% | $1.25 | +$5 M |
| Sells | 0 | ||||
| Net | +1 | +4 M | 100% | +$5 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rafael Holdings, Inc. | 10%+ Owner | $14.9 M | +$5 M | +50.5% | Oct 20, 2023 |
| N. Scott Fine | Chief Executive Officer, Director | $569 K | Jun 3, 2024 | ||
| Francis Patrick Ostronic | Director | $256 K | Jun 3, 2024 | ||
| Markus Sieger | Director | $242 K | Jun 3, 2024 | ||
| Ce Rick Strattan | Director | $210 K | Jun 3, 2024 | ||
| William S. Shanahan | Director | $89.3 K | Jun 3, 2024 | ||
| Randall M. Toig | Director | $81.8 K | Jun 3, 2024 | ||
| Jeffrey Tate | Chief Operating Officer, Director | $69.5 K | Jun 3, 2024 | ||
| Shawn Cross | Director | $57.9 K | Jun 3, 2024 | ||
| William Conkling | Director | $17.6 K | Jun 3, 2024 | ||
| Sharon Hrynkow | Chief Scientific Officer | $13.7 K | Dec 2, 2021 | ||
| Vivien Wong | Director | $11.8 K | Jun 3, 2024 | ||
| Joshua M. Fine | Chief Financial Officer | Jun 3, 2024 | |||
| Michael Lisjak | Chief Regulatory Officer | Jun 3, 2024 | |||
| Lise Lund Kjems | Chief Medical Officer | Mar 7, 2023 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|